This year, funds raised through Ride for Cancer powered by BMO Bank of Montreal will bring the QEII Health Sciences Centre one step closer to introducing new state-of-the-art genetic sequencing technology that will be used to analyze the genes of thousands of tumour samples each year. Better outcomes, fewer side effects, access to a new therapy or clinical trial are all benefits this technology brings to cancer patients, here at home. It can even spare patients from unnecessary treatments. This is a game-changer for those patients facing late-stage cancers.